Anticalins: exploiting a non-Ig scaffold with hypervariable loops for the engineering of binding proteins
A Richter1, E Eggenstein1, A Skerra1
1Munich Center for integrated Protein Science (CiPS-M) and Lehrstuhl für Biologische Chemie, Technische Universität München, Emil-Erlenmeyer-Forum 5, 85350 Freising-Weihenstephan, Germany.
FEBS Letters
|November 19, 2013
Summary
Researchers engineered Anticalins, novel binding proteins derived from human lipocalins, with high affinity for various targets. These engineered proteins show promise as a new class of biopharmaceuticals for medical applications.
Area of Science:
- Biotechnology
- Protein Engineering
- Immunology
Background:
- Antibodies are natural binding proteins, serving as a model for protein engineering.
- Lipocalins are a protein family with ligand-binding functions, featuring a conserved framework and variable loops.
- This structure makes lipocalins an ideal platform for engineering novel binding reagents.
Purpose of the Study:
- To engineer novel binding proteins, termed Anticalins, using the lipocalin platform.
- To develop Anticalins with high specificity and affinity for diverse targets relevant to research and medicine.
Main Methods:
- Utilizing recombinant/synthetic DNA technology.
- Employing combinatorial library selection methods.
- Engineering Anticalins derived from human lipocalins.
Main Results:
- Successfully generated Anticalins with picomolar affinities.
- Developed Anticalins targeting small molecules, peptides, protein signaling molecules, and cell surface receptors.
- Anticalins derived from human lipocalins have advanced to clinical trials.
Conclusions:
- Anticalins represent a versatile platform for creating targeted binding proteins.
- Their small size and single-polypeptide structure facilitate fusion protein construction.
- Anticalins hold significant potential as a new class of biopharmaceuticals.
Related Concept Videos
Assembly of Signaling Complexes
4.7K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
4.7K
Immunoglobulin-like Cell Adhesion Molecules
3.3K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
3.3K
Conserved Binding Sites
4.1K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.1K
Protein Complexes with Interchangeable Parts
2.1K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.1K
Ligand Binding and Linkage
4.4K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.4K
Calmodulin-dependent Signaling
5.0K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.0K


